The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during ...

A multicenter, registry-based cohort study showed no short-term benefit of the common practice of switching anticoagulants ...

While the age-specific analysis was welcome, some felt it didn’t dig deep enough and others questioned the bleeding endpoints ...

Adoption of DOAC population management tool dashboard before July 2018 linked to decline in off-label dosing prescriptions HealthDay News — Early adoption of the direct oral anticoagulant (DOAC) ...

The risk for death goes up for patients with atrial fibrillation (AF) who are put on direct oral anticoagulants (DOAC) at dosages other than those approved for stroke prevention, whether higher or ...

Carotid atherosclerosis was a common finding among patients with atrial fibrillation who experienced breakthrough stroke, regardless of anticoagulant use, researchers reported.The high prevalence of ...

The PROACT Xa trial has been halted prematurely after it was found that apixaban (Eliquis; Bristol Myers Squibb) carried a greater risk of blood clots leading to stroke when compared with warfarin in ...

Credit: Getty Images. This registry-based cohort study aimed to assess both the frequency of prescription of concomitant aspirin (ASA) and DOAC therapy as well as its effect on clinical outcomes in ...

Despite concerns about the potential bleeding risk, IV thrombolysis could be safely given to ischemic stroke patients within a day of direct oral anticoagulant (DOAC) therapy, according to ...

Study authors assessed the effectiveness and safety of DOACs compared with warfarin in patients with valvular atrial fibrillation. People with valvular atrial fibrillation (AF) who are new users of ...

Swedish cohort study shows 13% (95% CI, 2-22%) lower risk of kidney function decline or kidney failure and 12% (95% CI, 3-20%) lower risk of acute kidney injury with use of direct oral anticoagulants ...

The DOAC Dipstick (DOASENSE GmbH) is a single-use, point-of-care dipstick test that is used to detect direct oral anticoagulants (DOACs) in urine. The urine dipstick test detects DOACs (both factor Xa ...